Cancers

Journal

Publication Venue For

  • Genomic landscape of angiosarcoma: A targeted and immunotherapy biomarker analysis.  13. 2021
  • Targeted liposomal chemotherapies to treat triple-negative breast cancer.  13. 2021
  • The bet inhibitor JQ1 augments the antitumor efficacy of gemcitabine in preclinical models of pancreatic cancer.  13. 2021
  • Knocking out the vitamin d receptor enhances malignancy and decreases responsiveness to vitamin d3 hydroxyderivatives in human melanoma cells.  13. 2021
  • Serine-threonine kinase receptor-associated protein (Strap) knockout decreases the malignant phenotype in neuroblastoma cell lines.  13. 2021
  • Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors.  13. 2021
  • Diet-induced obesity impairs outcomes and induces multi-factorial deficiencies in effector t cell responses following anti-ctla-4 combinatorial immunotherapy in renal tumor-bearing mice.  13. 2021
  • Positron emission tomography imaging of macrophages in cancer.  13. 2021
  • Artificial tumor microenvironments in neuroblastoma.  13. 2021
  • Assessing preclinical research models for immunotherapy for gynecologic malignancies.  13. 2021
  • Identification of BXDC2 as a key downstream effector of the androgen receptor in modulating cisplatin sensitivity in bladder cancer.  13:1-13. 2021
  • Integrin αvβ3 engagement regulates glucose metabolism and migration through focal adhesion kinase (Fak) and protein arginine methyltransferase 5 (prmt5) in glioblastoma cells.  13:1-16. 2021
  • The effects of single nucleotide polymorphisms in cancer rnai therapies.  12:1-20. 2020
  • Elavl1 role in cell fusion and tunneling membrane nanotube formations with implication to treat glioma heterogeneity.  12:1-18. 2020
  • The antidiabetic agent acarbose improves anti-PD-1 and rapamycin efficacy in preclinical renal cancer.  12:1-19. 2020
  • Actively targeted nanodelivery of echinomycin induces autophagy-mediated death in chemoresistant pancreatic cancer in vivo.  12:1-17. 2020
  • MiR-216b/Smad3/BCL-2 axis is involved in smoking-mediated drug resistance in non-small cell lung cancer.  12:1-16. 2020
  • Association of allostatic load with all-cause and cancer mortality by race and body mass index in the regards cohort.  12:1-15. 2020
  • Identification of distinct heterogenic subtypes and molecular signatures associated with african ancestry in triple negative breast cancer using quantified genetic ancestry models in admixed race populations.  12. 2020
  • Patient-derived xenograft models of pancreatic cancer: Overview and comparison with other types of models.  12. 2020
  • Biological and clinical significance of the CCR5/CCL5 axis in hepatocellular carcinoma.  12. 2020
  • PAICS, a purine nucleotide metabolic enzyme, is involved in tumor growth and the metastasis of colorectal cancer.  12. 2020
  • Utilizing genome-wide mrna profiling to identify the cytotoxic chemotherapeutic mechanism of triazoloacridone C-1305 as direct microtubule stabilization.  12. 2020
  • Inhibiting WNT ligand production for improved immune recognition in the Ovarian tumor microenvironment.  12. 2020
  • An update on neurofibromatosis type 1-associated gliomas.  12. 2020
  • Cachexia and sarcopenia in older adults with cancer: A comprehensive review.  11. 2019
  • Immunotherapy in pediatric solid tumors—a systematic review.  11. 2019
  • Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity..  11. 2019
  • Prognostic role of androgen receptor in triple negative breast cancer: A multi-institutional study.  11. 2019
  • A review of the role of wnt in cancer immunomodulation.  11. 2019
  • Pulmonary carcinoid surface receptor modulation using histone deacetylase inhibitors.  11. 2019
  • Genomic profiling of the steroidogenic acute regulatory protein in breast cancer: In silico assessments and a mechanistic perspective.  11. 2019
  • Review: Targeting the transforming growth factor-beta pathway in ovarian cancer.  11. 2019
  • Effects of SAHA and EGCG on growth potentiation of triple-negative breast cancer cells.  11. 2019
  • Contemporary management of localized resectable pancreatic cancer.  10. 2018
  • Regulation of EMT in colorectal cancer: A culprit in metastasis.  9. 2017
  • The impact of DNA repair pathways in cancer biology and therapy.  9. 2017
  • Cell proliferation in neuroblastoma.  8. 2016
  • Cancer stem cells and their interaction with the tumor microenvironment in neuroblastoma.  8:1-13. 2015
  • Aberrant GLI1 activation in DNA damage response, carcinogenesis and chemoresistance.  7:2330-2352. 2015
  • The impact of hedgehog signaling pathway on DNA repair mechanisms in human cancer.  7:1333-1348. 2015
  • PARP-1: Friend or foe of DNA damage and repair in tumorigenesis?.  5:943-958. 2013
  • Advances in viral vector-based TRAIL gene therapy for cancer.  3:603-620. 2011
  • Cancer stem cells and pediatric solid tumors.  3:298-318. 2011
  • Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells.  3:621-635. 2011
  • International Standard Serial Number (issn)

  • 2072-6694
  • Electronic International Standard Serial Number (eissn)

  • 2072-6694